CIK 0001731348 · Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- operating
- EIN
- 824310622
- Phone
- 519.322.8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-01 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | +139,806 | $1.70 | $238K | 250,203 |
| 2023-06-01 | FALTISCHEK DENISE M Chief Strategy Officer | Shares withheld for taxes | −71,372 | $1.70 | $121K | 178,831 |
| 2023-06-01 | FALTISCHEK DENISE M Chief Strategy Officer | Returned to the company · Restricted Stock Units ("2021 LTIP RSUs") | −16,219 | 16,224 | ||
| 2023-06-01 | FALTISCHEK DENISE M Chief Strategy Officer | Returned to the company · Restricted Stock Units ("2022 LTIP RSUs") | −123,587 | 123,588 | ||
| 2023-06-01 | Merton Carl A Chief Financial Officer | Option exercise | +108,971 | $1.70 | $185K | 377,152 |
| 2023-06-01 | Merton Carl A Chief Financial Officer | Shares withheld for taxes | −54,661 | $1.70 | $93K | 322,491 |
| 2023-06-01 | Merton Carl A Chief Financial Officer | Returned to the company · Restricted Stock Units ("2021 LTIP RSUs") | −16,219 | 16,224 | ||
| 2023-06-01 | Merton Carl A Chief Financial Officer | Returned to the company · Restricted Stock Units ("2022 LTIP RSUs") | −92,752 | 92,753 | ||
| 2022-11-07 | Kennedy Brendan Director | Sale | −350,000 | $3.78 | $1.3M | 6,224,196 |
| 2022-10-05 | Kennedy Brendan Director | Sale | −350,000 | $2.91 | $1.0M | 6,574,196 |
| 2022-09-06 | Kennedy Brendan Director | Sale | −350,000 | $3.22 | $1.1M | 6,924,196 |
| 2022-08-17 | Merton Carl A Chief Financial Officer | Grant or award | +20,750 | 279,179 | ||
| 2022-08-17 | Merton Carl A Chief Financial Officer | Returned to the company | −10,998 | $4.06 | $45K | 268,181 |
| 2022-08-17 | Merton Carl A Chief Financial Officer | Option exercise · RSUs | −20,750 | 0 | ||
| 2022-08-09 | Hopkinson David G. Director | Option exercise | −12,000 | $3.90 | $47K | 3,314 |
| 2022-08-05 | Kennedy Brendan Director | Sale | −350,000 | $3.91 | $1.4M | 7,274,196 |
| 2022-08-03 | Merton Carl A Chief Financial Officer | Option exercise | +23,089 | 270,667 | ||
| 2022-08-03 | Merton Carl A Chief Financial Officer | Shares withheld for taxes | −12,238 | $3.88 | $47K | 258,429 |
| 2022-08-03 | Merton Carl A Chief Financial Officer | Option exercise · RSUs | −23,089 | 0 | ||
| 2022-07-27 | SIMON IRWIN D President and CEO | Option exercise | +196,386 | 1,023,841 |
Page 17 of 35 · 686 trades